000 01187 a2200325 4500
005 20250513044523.0
264 0 _c19950210
008 199502s 0 0 eng d
022 _a0007-1048
024 7 _a10.1111/j.1365-2141.1994.tb05093.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaung, Z T
245 0 0 _aTransfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
_h[electronic resource]
260 _bBritish journal of haematology
_cNov 1994
300 _a649-52 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aGraft vs Host Disease
_xetiology
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdrug therapy
650 0 4 _aTransfusion Reaction
650 0 4 _aVidarabine
_xadverse effects
700 1 _aWood, A C
700 1 _aJackson, G H
700 1 _aTurner, G E
700 1 _aAppleton, A L
700 1 _aHamilton, P J
773 0 _tBritish journal of haematology
_gvol. 88
_gno. 3
_gp. 649-52
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.1994.tb05093.x
_zAvailable from publisher's website
999 _c7818440
_d7818440